In mouse melanoma B16-F10 and YUMMER1.7 tumor models, the combined administration of CBL0137 and PD-1 antibodies significantly reduced tumor volume in a ZBP1-dependent manner. The gene discussed is ZBP1; the disease is neoplasm.